To address clinical unmet needs and support
better human health, become one of the top
tier pharmaceutical companies in China.
Better Generics
Superior Innovatives
Agility
Innovation
Be Reslistic
Collaboration
Ownership
R & D System
Huilun is devoted to the development of both generic and innovative drugs to fulfil the unmet clinical needs.
R & D Platform
Preclinical Research Platform
Pharmaceutical Research Platform
Clinical Research Platform
R & D Team
We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.
R & D Achievements
Over 40 clinical trial permissions approved by CFDA
Over 20 drugs were applied for the
manufacturing licenses with 10+ approved Over 10 APIs passed review
R & D System
Huilun is devoted to the development of both generic and innovative drugs to fulfil the unmet clinical needs.
More
R & D Platform
Preclinical Research Platform <br> Pharmaceutical Research Platform<br> Clinical Research Platform
More
R & D Team
We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.
More
R & D Achievements
Over 40 clinical trial permissions approved by CFDA<br> Over 20 drugs were applied for the<br> manufacturing licenses with 10+ approved Over 10 APIs passed review
More
2024年05月
14
上海匯倫湖北制藥有限公司原料藥基地建設(shè)項(xiàng)目A1車間低壓配電柜采購(gòu)?fù)稑?biāo)邀請(qǐng)書(shū)
2024年05月
13
上海匯倫湖北制藥有限公司A1車間廢氣收集及預(yù)處理系統(tǒng)招標(biāo)邀請(qǐng)書(shū)
2024年03月
07
醫(yī)藥代表信息備案公示
響應(yīng)《醫(yī)藥代表備案制管理辦法（試行）》的相關(guān)要求，現(xiàn)將上海匯倫醫(yī)藥股份有限公司現(xiàn)有醫(yī)藥代表的詳細(xì)備案信息進(jìn)行公示。
